Compare SOC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOC | IMTX |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2021 | 2020 |
| Metric | SOC | IMTX |
|---|---|---|
| Price | $4.31 | $8.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $17.33 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 6.5M | 565.9K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $73.55 | $25.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.88 | $6.90 |
| 52 Week High | $24.64 | $12.41 |
| Indicator | SOC | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 44.96 |
| Support Level | $3.94 | $8.36 |
| Resistance Level | $4.61 | $10.51 |
| Average True Range (ATR) | 0.33 | 0.34 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 16.09 | 34.57 |
Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.